PRESS RELEASE published on 09/03/2024 at 22:15, 1 year 7 months ago Nanobiotix to Present at H.C. Wainwright 26th Annual Global Investment Conference Nanobiotix to present at H.C. Wainwright 26th Annual Global Investment Conference. Company management to participate in fireside chat on September 11, 2024 Biotechnology Cancer H.C. Wainwright NANOBIOTIX Global Investment Conference
BRIEF published on 08/08/2024 at 22:20, 1 year 8 months ago Nanobiotix: Information on Voting Rights and Shares as of July 31, 2024 Share Capital Voting Rights Actions Sotck Exchange NANOBIOTIX
PRESS RELEASE published on 08/08/2024 at 22:15, 1 year 8 months ago Voting Rights and Shares Capital of the Company Nanobiotix announces monthly publication of voting rights and shares capital in compliance with French Commercial Code. Learn more about the company's disruptive biotechnology approaches Voting Rights French Commercial Code Biotechnology Shares Capital NANOBIOTIX
BRIEF published on 07/09/2024 at 22:20, 1 year 9 months ago Voting Rights and Shares Capital of Nanobiotix Voting Rights Shares Euronext Nasdaq NANOBIOTIX
PRESS RELEASE published on 07/09/2024 at 22:15, 1 year 9 months ago Voting Rights and Shares Capital of the Company Nanobiotix discloses voting rights and shares capital information as per French Commercial Code. Check the latest figures for June 30, 2024 Euronext Paris Voting Rights French Commercial Code Shares Capital NANOBIOTIX
BRIEF published on 07/03/2024 at 15:54, 1 year 9 months ago Threshold crossings at NANOBIOTIX by Goldman Sachs Group AMF Goldman Sachs NANOBIOTIX Threshold Crossings
BRIEF published on 06/12/2024 at 22:20, 1 year 10 months ago Nanobiotix hosts virtual discussion on the potential of NBTXR3 in cancer treatments Immunotherapy Head And Neck Cancer NANOBIOTIX NBTXR3 Virtual Discussion
PRESS RELEASE published on 06/12/2024 at 22:15, 1 year 10 months ago NANOBIOTIX to Host Virtual KOL Event Discussing Potential of NBTXR3 Combined With Immunotherapy in Head and Neck Cancer and Beyond on June 18, 2024 Nanobiotix to host virtual KOL event discussing NBTXR3 combined with immunotherapy in head and neck cancer and beyond on June 18, 2024 Immunotherapy Head And Neck Cancer NANOBIOTIX NBTXR3 Virtual KOL Event
BRIEF published on 06/11/2024 at 22:20, 1 year 10 months ago Nanobiotix: Monthly Information on Voting Rights and Shares Voting Rights Euronext Actions Nasdaq NANOBIOTIX
PRESS RELEASE published on 06/11/2024 at 22:15, 1 year 10 months ago Voting Rights and Shares Capital of the Company Nanobiotix discloses its voting rights and shares capital information as of May 31, 2024, in compliance with regulatory requirements. The company is a clinical biotechnology firm listed on Euronext Paris and Nasdaq Euronext Paris Voting Rights Nasdaq Shares Capital NANOBIOTIX
Published on 05/02/2026 at 01:30, 2 hours 29 minutes ago Uraniumx Reports Strong Financial Position Ahead of Spring Drill Program
Published on 05/02/2026 at 00:50, 3 hours 9 minutes ago CoTec Announces Annual Stock Option, Restricted Share Unit And Deferred Share Unit Grants
Published on 05/02/2026 at 00:00, 3 hours 59 minutes ago Redwood AI Announces Enhanced AI Models, Increasing Evaluated Chemical Reactions Following Preliminary Results from UBC Collaboration
Published on 05/02/2026 at 00:00, 3 hours 59 minutes ago Onco-Innovations Expands Manufacturing Scale-Up of Its PNKP Inhibitor Technology with Dalton Pharma Services, Advancing Multi-Kilogram Non-GMP Synthesis to Support IND-Enabling Studies
Published on 05/01/2026 at 22:30, 5 hours 29 minutes ago Nextech3D.ai Appoints New Independent Auditor
Published on 05/01/2026 at 19:23, 8 hours 36 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 05/01/2026 at 17:45, 10 hours 14 minutes ago Burkhalter Group acquires Progressio Holding GmbH and anplaq ag, Tamins (GR)
Published on 05/01/2026 at 17:21, 10 hours 37 minutes ago Fuller, Smith & Turner PLC: Total Voting Rights and Treasury Shares
Published on 04/30/2026 at 20:00, 1 day 7 hours ago AMA Corp PLC : FY 2025 Earnings & Q1 2026 Revenue
Published on 04/30/2026 at 19:16, 1 day 8 hours ago AXA announces the results of its Shareholders' Meeting
Published on 04/30/2026 at 19:00, 1 day 8 hours ago Capital increase through exercise of subscription rights
Published on 04/30/2026 at 18:10, 1 day 9 hours ago Minutes of the Combined General Meeting held on April 30, 2026
